Sobi is an international bio-pharmaceutical company focused on rare diseases and dedicated to providing access to innovative treatments. With a focus on two therapeutic areas: Hematology and Immunology, and a portfolio of Specialty Care products, we are committed to treating people with hemophilia A and B, chronic ITP, and PNH.